Author/Authors :
Hejazi, H Department of Parasitology - Isfahan University of Medical Sciences, Isfahan, Iran , Tasbihi, M Department of Parasitology - Isfahan University of Medical Sciences, Isfahan, Iran , Jaafari, MR Biotechnology Research Center and Nanotechnology Research Center - School of Pharmacy - Mashhad University of Medical Sciences, Mashhad, Iran , Badiee, A Biotechnology Research Center and Nanotechnology Research Center - School of Pharmacy - Mashhad University of Medical Sciences, Mashhad, Iran , Pestechian, N Department of Parasitology - Isfahan University of Medical Sciences, Isfahan, Iran , Javadi, A Department of Social Medicine - Qazvin University of Medical Sciences, Qazvin, Iran , Khamesipour, A Center for Research and Training in Skin Diseases and Leprosy - Tehran University of Medical Sciences, Tehran, Iran
Abstract :
Background: Historically, leishmanization is the most effective protective measure against Cutaneous
Leishmaniasis (CL), CL lesion induced by leishmanization sometimes takes a long time to heal. Manipulation
of leishmanization inoculums needed to induce a mild and acceptable CL lesion. The aim of
this study was to explore if liposomal form of CpG ODN (Cytosin phosphate Guanin Oligodeoxynucleotides)
mixed with Leishmania major would induce a milder lesion size in Balb/c mice.
Methods: This study was performed in Biotechnology Research Center, Mashhad, and Center for Research
and Training in Skin Diseases and Leprosy, Tehran, Iran during 2008-2009. Different groups of
BALB/c mice were subcutaneously (SC) inoculated with L. major mixed with liposomal form of CpG
ODN, or L. major plus free CpG ODN, or L. major mixed with empty liposomes or L. major in PBS.
The lesion onset and the size of lesion were recorded; the death rate was also monitored.
Result: Footpad thickness was significantly (P<0.01) smaller, death rate was also significantly
(P<0.05) lower in the mice received L. major mixed with liposomal CpG ODN or free CpG ODN than
control groups received L. major in PBS or L. major plus liposomes, also mice which received L. major
mixed with CpG ODN in soluble form showed a significantly (P < 0.001) smaller lesion size than
control groups.
Conclusion: CpG ODN seems to be an appropriate immunopotentiator mixed with Leishmania stabilate
in leishmanization.
Keywords :
CpG ODN , Liposome , Leishmania major , BALB/c